Moderna plans to launch 10 new marketed products over the next three years, aiming to diversify a revenue base, which is ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

Moderna (NASDAQ:MRNA) was in focus Thursday morning after the vaccine maker announced plans to expand its cost efficiency and ...

THURSDAY, May 8, 2025 (HealthDay News) — A new vaccine that combines flu and COVID-19 protection in one shot shows promising ...

The trial found that antibody levels were higher for COVID and all but one flu strain in those who got the combo.

A new trial suggests a combination vaccine may offer equal or better protection against both flu and covid-19 compared to current vaccines. We may earn a commission when you buy through links on our ...

Two Washington state doctors backed by RFK Jr. accuse the state of stomping on their free speech rights by investigating them ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

Moderna’s study, involving 8,000 adults 50 and older, showed the new combo shot generated an immune response against COVID and most strains of flu compared to existing stand-alone shots.